Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
603168.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.26B
Close$
$-5.71
196.9% downside
Current Fair Value
196.9% downsideOvervalued by 196.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.26 Billion |
|---|---|
| Enterprise Value | $2.50 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.64 |
| Beta | 0.12 |
| Outstanding Shares | 372,514,005 |
Return
| Return on Equity | -17.59% |
|---|---|
| Return on Assets | -13.33% |
| Return on Invested Capital | -22.13% |
Valuation & Multiples
| P/E Ratio | -9.19 |
|---|---|
| PEG | -3.67 |
| Price to Sales | 5.89 |
| Price to Book Ratio | 1.96 |
| Enterprise Value to Revenue | 5.9 |
| Enterprise Value to EBIT | -7.75 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
1,142 employees
CEO: Hong Li Lin Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It of...